Company Filing History:
Years Active: 2003-2006
Title: Innovations by Jean Christophe Renauld
Introduction
Jean Christophe Renauld is a notable inventor based in Kraainem, Belgium. He has made significant contributions to the field of immunology, particularly in the development of cytokine-specific antibodies. With a total of 2 patents to his name, Renauld's work has the potential to impact the treatment of various pathological conditions.
Latest Patents
Renauld's latest patents include a "Method for making cytokine specific antibodies and uses thereof." This invention focuses on immunizing animals with conjugates of cytokines and a carrier to induce a prolonged high titre antibody response specific for the cytokine. The invention addresses the treatment of pathological conditions such as eosinophilia and allograft rejection, which are associated with the production of cytokines, particularly interleukins like IL-4, IL-5, IL-9, and IL-13. Additionally, it encompasses compositions comprising the cytokine conjugates and the conjugates themselves. Another patent, "Method of treatment with IL-9 conjugate," shares similar methodologies and applications, emphasizing the importance of cytokine conjugates in immunization and treatment.
Career Highlights
Jean Christophe Renauld is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research in immunology. His work is pivotal in understanding and treating conditions related to cytokine production.
Collaborations
Renauld has collaborated with esteemed colleagues such as Jacques Van Snick and Mélisande Richard, contributing to the advancement of research in his field.
Conclusion
Jean Christophe Renauld's innovative work in the development of cytokine-specific antibodies showcases his commitment to advancing medical science. His patents hold promise for improving treatments for various health conditions, marking him as a significant figure in the field of immunology.